FDA Inspection 1029821 — Valentyna Berezenko, M.D., Ph.D.
The FDA completed an inspection of Valentyna Berezenko, M.D., Ph.D. on August 25, 2017 in Kyiv. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 25, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kyiv (Ukraine)
Additional Details
Clinical Investigator (CI)